Angiodynamics (ANGO) Inventory (2011 - 2026)

Angiodynamics has reported Inventory for 16 years, with the latest figure at $58.6 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 7.17% year-over-year to $58.6 million; the trailing twelve-month figure through Feb 2026 stood at $58.6 million (down 7.17% YoY), and the FY2025 full-year result was $62.0 million, up 2.29% from the prior year.
• Inventory for Q1 2026 stood at $58.6 million, down from $65.6 million in the prior quarter.
• The five-year high for Inventory was $65.9 million in Q4 2024, with the low at $48.0 million in Q1 2022.
• Historically, Inventory has averaged $60.2 million across 5 years, with a median of $62.0 million in 2025.
• Annual changes were most pronounced in 2023 — Inventory soared 32.25% — and 2024, when it dropped 8.6%.
• Angiodynamics' Inventory stood at $63.2 million in 2022, then grew by 1.7% to $64.3 million in 2023, then climbed by 2.59% to $65.9 million in 2024, then declined by 0.53% to $65.6 million in 2025, then fell by 10.66% to $58.6 million in 2026.
• The last three Inventory figures came in at $58.6 million (Q1 2026), $65.6 million (Q4 2025), and $62.3 million (Q3 2025), per Business Quant data.